课题基金 / 基金详情

APPLICATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY IN SURGERY : EARLY DETECTION OF PREVENTION OF POSTOPERATIVE RECURRENCE AND METASTASIS

APPLICATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY IN SURGERY : EARLY DETECTION OF PREVENTION OF POSTOPERATIVE RECURRENCE AND METASTASIS
端粒长度和端粒酶活性在手术中的应用:早期检测预防术后复发和转移
批准号:
09470250
负责人:
HIYAMA Eiso
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

HIYAMA Eiso的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Postoperative reoccurrence and metastasis is difficult to be predicted at surgery. To evaluate alterations of telomere length and telomerase activity as biomarkers for postoperative reoccurrence/metastasis, we analyzed the correlation between those parameters and clinical status (stages, prognosis, recurrence, etc) in 653 adult and 164 childhood cancer specimens.Shortened telomere (length of terminal restriction fragments <less than or equal>8 kb) was detected in 1 9-50% and elongated telomere (<greater than or equal> 15 kb) was in 0-19%. Telomerase activation was detectable in 48-1 00% of these tumors. High telomerase activity was detected in various percentages (17-88%) of each type of these tumors. In pancreatic cancer and rhabdomyosarcoma specimens, high telomerase activity was detected in more than 80%. Significantly high percentages of postoperative reoccurrence/metastasis occurred in the cases with high telomerase activity and shortened telomere, which were considered to be usef … More ul markers to predict of postoperative reoccurreAmong these cases, we examined the expression of human telomerase RNA component (hTR) and human telomerase reverse transcriptase (hTERT) mRNA using in situ hybridization or in situ PCR.In the cancers with high telomerase activity, almost all cancer cells showed hTERT and hTR expressions, whereas cancer tissues with low telomerase activity showed heterogeneity of their expressions among composing cells. In the tissue specimens, expression levels of telomerase activity using in situ TRAP were equivalent with the hTERT expression levels. Thus, hTERT expression levels in frozen tissues is considered to be a useful recurrence/metastasis-predicting indicator. Then, we established the method for detecting hTERT expression by RT-PCR.Among these cases, we obtained liver biopsy and intraperitoneal lavage samples under informed consents. Telomerase activity, telomere length, hTR, and hTERT mRNA expression in these samples was not significantly correlated with postoperative reoccurrence/metastasis. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
檜山英三: "消化器癌とテロメラーゼ" 内科. 79・1. 358-359 (1997)
桧山英三:《胃肠癌与端粒酶》内科79・1(1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamanishi Y: "Telomerase activity in rheumatoid synovium correlates with the mononuclear cell infiltration level and disease aggressiveness of rheumatoid arthritis." J.Rheumatol.25・2. 214-220 (1998)
Yamanishi Y:“类风湿性滑膜中的端粒酶活性与类风湿性关节炎的单核细胞浸润水平和疾病侵袭性相关。”J.Rheumatol.25·2(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Keiko Hiyama: "Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases" International Journal of Molecular Meddicine. 1・3. 545-549 (1998)
Keiko Hiyama:“端粒酶活性作为肺癌和免疫相关肺部疾病的新标志物”,《国际分子医学杂志》1·3(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
檜山桂子: "ヒトの悪性腫瘍におけるテロメラーゼ." 炎症と免疫. 6・6. 53-58 (1998)
Keiko Hiyama:“人类恶性肿瘤中的端粒酶”,53-58(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
38
    Analysis of genomic aberrations, risk of secondary cancer development and, hereditary effects by irradiation and chemotherapy in children
    • 批准号:
      26670764
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Genomic aberrations by chemoradiotherapy in children and its transfer to next generation
    • 批准号:
      25670743
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Detection of molecular targets for childhood cancers using genomics and cellomics: targeting for cancer stem cells
    • 批准号:
      24249084
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.37万
    • 财政年份:
      2012
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Survey of childhood liver tumors in Asian area and infrastructural development of international collaboration study by Japanese study group for pediatric liver tumors (JPLT)
    • 批准号:
      23256006
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.29万
    • 财政年份:
      2011
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    国内基金
    海外基金
    SAGE1通过调控TERT转录促进肿瘤细胞增殖的机制研究
    • 批准号:
      32100582
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      葛云辉
    • 依托单位:
    HnRNP F/H在调控端粒酶活性、组装和转运中的作用和机制研究
    • 批准号:
      32070733
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      陈军
    • 依托单位:
    CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
    • 批准号:
      31900521
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2019
    • 负责人:
      冯旭阳
    • 依托单位:
    CMSS1/RBM34/DDX5复合体调控端粒酶新机制的发现及其在非小细胞肺癌(NSCLC)发生发展中的作用机制
    • 批准号:
      31972889
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      颜廷东
    • 依托单位: